TelyRx News Releases

TelyRx Announces First Quarter 2026 Financial Results

Tue, 12 May 2026 17:57:00 -0400

Clearwater, Florida--(Newsfile Corp. - May 12, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced financial results for the first quarter ended March 31, 2026. All dollar amounts are expressed in U.S. dollars.Highlights for the First Quarter of 2026Revenue increased to $19.4 million, compared to $14.3 million in Q4 2025 and $6.9 million in Q1 2025Number of Prescriptions Filled...

TelyRx to Host First Quarter 2026 Financial Results Conference Call on Wednesday, May 13, 2026 at 8:30 am ET

Tue, 12 May 2026 10:45:00 -0400

Clearwater, Florida--(Newsfile Corp. - May 12, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its first quarter 2026 financial results on Wednesday, May 13, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its first quarter 2026 financial results for the period ended March 31, 2026, after market close...

TelyRx Announces Year-End 2025 Financial Results

Tue, 21 Apr 2026 16:49:00 -0400

Clearwater, Florida--(Newsfile Corp. - April 21, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today filed audited financial statements for TelyRx, Inc., its wholly-owned subsidiary and reverse takeover acquirer, on SEDAR+ for the year ended December 31, 2025. All dollar amounts are expressed in U.S. dollars.Highlights for the Year and Fourth Quarter of 2025Revenue increased to $42.9...

TelyRx Holdings Inc. to Commence Trading on the Toronto Stock Exchange Effective April 7, 2026

Tue, 07 Apr 2026 07:00:00 -0400

Clearwater, Florida--(Newsfile Corp. - April 7, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced that its subordinate voting shares will commence trading on the Toronto Stock Exchange ("TSX") under the ticker symbol "TELY" effective Tuesday, April 7, 2026. This milestone follows the completion of its go-public transaction pursuant to the combination with Apolo V Acquisition...

Apolo V Acquisition Corp. Announces Filing of Filing Statement in Connection with Qualifying Transaction

Tue, 24 Mar 2026 20:33:00 -0400

Toronto, Ontario--(Newsfile Corp. - March 24, 2026) - Apolo V Acquisition Corp. (TSXV: AFV.P) ("Apolo V") is pleased to announce that it has filed its filing statement (the "Filing Statement") dated March 24, 2026 on its SEDAR+ profile in connection with the proposed business combination among Apolo V, TelyRx, Inc. ("TelyRx"), TelyRx Finco Inc. ("Finco"), 1001474388 Ontario Inc., and Apolo V MergerCo Inc. (the "Proposed Transaction"). In conjunction with, and on or about March 26, 2026, Finco is...

Apolo V Acquisition Corp. Announces Shareholder Approvals

Fri, 06 Mar 2026 09:08:00 -0500

Toronto, Ontario--(Newsfile Corp. - March 6, 2026) - Apolo V Acquisition Corp. (TSXV: AFV.P) ("Apolo" or the "Company"), a "capital pool company" pursuant to the policies of the TSX Venture Exchange (the "TSXV"), is pleased to announce the voting results from its Special Meeting of Shareholders (the "Apolo Meeting") held on Thursday, March 5, 2026 in connection with its previously announced proposed qualifying transaction (the "Qualifying Transaction") with TelyRx, Inc. ("TelyRx"). All matters...

Apolo V Acquisition Corp. Amendment to Definitive Agreement with TelyRx, Inc. and Rescheduling of Special Meeting of Shareholders

Fri, 20 Feb 2026 12:10:00 -0500

Toronto, Ontario--(Newsfile Corp. - February 20, 2026) - Apolo V Acquisition Corp. (TSXV: AFV.P) ("Apolo V" or the "Company") announces it has amended its business combination agreement with TelyRx, Inc. ("TelyRx") dated January 19, 2026 (the "Business Combination Agreement") effected in connection with its previously announced proposed qualifying transaction (the "Qualifying Transaction") and postponed its special meeting of shareholders (the "Meeting"), which had been scheduled to be held on...

Apolo V Acquisition Corp. Enters into Definitive Agreement with Telyrx, Inc.

Wed, 21 Jan 2026 16:42:00 -0500

Toronto, Ontario--(Newsfile Corp. - January 21, 2026) - Apolo V Acquisition Corp. (TSXV: AFV.P) ("Apolo V" or the "Company") and TelyRx, Inc. ("TelyRx"), a vertically integrated technology enabled healthcare and pharmacy services company, are pleased to announce they have entered into a business combination agreement dated January 19, 2026 (the "Business Combination Agreement"), among others, to complete a go-public transaction for TelyRx (the "Proposed Transaction") that will constitute Apolo...

Apolo V Acquisition Corp. and TelyRx, Inc. Enter into Letter of Intent to Complete Qualifying Transaction

Fri, 05 Dec 2025 14:25:00 -0500

Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Apolo V Acquisition Corp. (TSXV: AFV.P) ("Apolo") and TelyRx, Inc. ("TelyRx"), a vertically integrated technology enabled healthcare and pharmacy services company, are pleased to announce that they have entered into a non-binding letter of intent dated December 5, 2025, which outlines the principle terms and conditions pursuant to which Apolo and TelyRx will complete a transaction that will result in a reverse take-over of Apolo by TelyRx...

Apolo V Acquisition Corp. Completes Initial Public Offering

Fri, 24 Oct 2025 10:18:00 -0400

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH US NEWSWIRE SERVICESToronto, Ontario--(Newsfile Corp. - October 24, 2025) - Apolo V Acquisition Corp. (the "Corporation"), a capital pool company ("CPC") as defined under Policy 2.4 - Capital Pool Companies (the "CPC Policy") of the TSX Venture Exchange (the "Exchange"), is pleased to announce that it has successfully completed an initial public offering (the "IPO") of 8,000,000 common shares of the Corporation (each, a "Common Share") at a...